Bank of New York Mellon »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-09-30 $477k 400k 1.19
2024-06-30 $667k 600k 1.11
2024-03-31 $585k 600k 0.97
2023-12-31 $559k 600k 0.93

More positions owned by Bank of New York Mellon

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Inc-class A Cl A (META)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Cap (GOOGL)
Alphabet Inc-cl C Cap (GOOG)
Broadcom (AVGO)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Mastercard Inc - A Cl A (MA)
UnitedHealth (UNH)
Exxon Mobil Corporation (XOM)

View all positions for Bank of New York Mellon

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1